AGP Executive Report
Last update: 5 hours agoPharma Court Fight: Novo Nordisk sued Eli Lilly in New Jersey federal court, accusing Lilly of “deceptive” GLP-1 ads that use outdated dose comparisons and omit key context, escalating the Ozempic/Wegovy vs Mounjaro/Zepbound rivalry. Public Health Watch: Health officials are still tracing a cyclosporiasis outbreak, urging clinicians to test for Cyclospora in patients with persistent watery diarrhea and other GI symptoms as case counts remain far above last year. NJ Innovation Impact: NJIT and the state’s CSIT program say early-stage grants leveraged $26.8M into $524.5M in follow-on funding, supporting nearly 1,800 jobs and boosting NJ’s innovation economy. AI + Telecom Deal: Xtel Communications acquired SimpliMeta to expand engineering, professional services, and AI delivery for government, schools, and medical customers across New Jersey. Space Science in NJ: New research on a meteorite that crashed into a NJ home reports “alien world chemistry” and prebiotic building blocks tied to early solar system processes. Weather Disruption: Severe storms triggered mass flight cancellations across the NYC/Newark area, with airlines issuing waivers as heavy rain and damaging winds hit. Health Research: A new study links sugar substitutes to faster cognitive decline, adding to growing debate over long-term effects of low-calorie sweeteners.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
